Maternal Tdap vaccination: Coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013

Vaccine

Volumn 34, Issue 7, 2016, Pages 968-973

  Kharbanda, Elyse Olshen ^a   Vazquez Benitez, Gabriela ^a   Lipkind, Heather S ^b   Klein, Nicola P ^c   Cheetham, T Craig ^c   Naleway, Allison L ^c   Lee, Grace M ^d   Hambidge, Simon ^e   Jackson, Michael L ^f   Omer, Saad B ^c   McCarthy, Natalie ^g   Nordin, James D ^a  

^a HEALTHPARTNERS INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KAISER PERMANENTE   (United States)

^d HARVARD PILGRIM HEALTH CARE INSTITUTE   (United States)

^e DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^f CENTER FOR HEALTH STUDIES   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Maternal vaccination; Tdap; Vaccine coverage; Vaccine safety

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; COHORT ANALYSIS; CONTROLLED STUDY; CRANIAL NERVE INJURY; DEMYELINATING DISEASE; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; GUILLAIN BARRE SYNDROME; HEART DISEASE; HIGH RISK PREGNANCY; HOSPITALIZATION; HUMAN; LIVE BIRTH; LUNG DISEASE; MAJOR CLINICAL STUDY; MALAISE; MATERNAL AGE; MATERNAL HYPERTENSION; MENINGOENCEPHALITIS; MENTAL HEALTH; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; PARALYSIS; PERICARDITIS; PERIPHERAL NEUROPATHY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; SEIZURE; SIDE EFFECT; THIRD TRIMESTER PREGNANCY; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOSIS; VACCINATION; VENOUS THROMBOEMBOLISM; ADVERSE EFFECTS; CASE CONTROL STUDY; MIDDLE AGED; PREGNANCY; RISK; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; RETROSPECTIVE STUDIES; RISK; VACCINATION; YOUNG ADULT;

EID: 84957849414     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.12.046     Document Type: Article

References (42)

1. Pertussis epidemic-Washington MMWR Morb Mortal Wkly Rep. Jul 20 2012 2012, 61(28):517-522.
2. Cherry J.D. Epidemic pertussis in 2012-the resurgence of a vaccine-preventable disease. N Engl J Med 2012, 367(9):785-787. Aug 30.
3. Winter K., Harriman K., Zipprich J., Shechter R., Talarico J., Watt J., et al. California pertussis epidemic, 2010. J Pediatr 2012, 161(December (6)):1091-1096.
4. Winter K., Glaser C., Watt J., Harriman K. Pertussis Epidemic - California, 2014. Morbid Mortal Wkly Rep 2014, 63(48):1129-1132.
5. van Hoek A.J., Campbell H., Amirthalingam G., Andrews N., Miller E. The number of deaths among infants under one year of age in England with pertussis: results of a capture/recapture analysis for the period 2001 to 2011. Euro surveill 2013, 18(9).
6. Vilajeliu A., Gonce A., Lopez M., Costa J., Rocamora L., Rios J., et al. Combined tetanus-diphtheria and pertussis vaccine during pregnancy: transfer of maternal pertussis antibodies to the newborn. Vaccine 2015, 33(February (8)):1056-1062.
7. Terranella A., Asay G.R., Messonnier M.L., Clark T.A., Liang J.L. Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis. Pediatrics 2013, 131(June (6)):e1748-e1756.
8. Amirthalingam G., Andrews N., Campbell H., Ribeiro S., Kara E., Donegan K., et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014, July.
9. Healy C.M., Rench M.A., Baker C.J. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis 2013, 56(February (4)):539-544.
10. CDPH Broadens recommendations for vaccinating against pertussis: immunization key to controlling whooping cough. [accessed on 02.12.13]. http://www.cdph.ca.gov/Pages/PH10-048.aspx.
11. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011, 60(October (41)):1424-1426.
12. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women-Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013, 62(February (7)):131-135.
13. Kharbanda E.O., Vazquez-Benitez G., Lipkind H., Naleway A.L., Klein N.P., Cheetham T.C. Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink Sites. Prev Med 2014, June.
14. Ahluwalia I.B., Ding H., D'Angelo D., Shealy K.H., Singleton J.A., Liang J., et al. Tetanus, diphtheria, pertussis vaccination coverage before, during, and after pregnancy - 16 States and new york city, 2011. MMWR Morb Mortal Wkly Rep 2015, 64(May (19)):522-526.
15. Healy C.M., Ng N., Taylor R.S., Rench M.A., Swaim L.S. Tetanus and diphtheria toxoids and acellular pertussis vaccine uptake during pregnancy in a metropolitan tertiary care center. Vaccine 2015, July.
16. Koepke R., Kahn D., Petit A.B., Schauer S.L., Hopfensperger D.J., Conway J.H., et al. Pertussis and Influenza Vaccination Among Insured Pregnant Women - Wisconsin, 2013-2014. MMWR Morb Mortal Wkly Rep 2015, 64(July (27)):746-750.
17. Chamberlain A.T., Seib K., Ault K.A., Orenstein W.A., Frew P.M., Malik F., et al. Factors associated with intention to receive influenza and tetanus, diphtheria, and acellular pertussis (Tdap) vaccines during pregnancy: a focus on vaccine hesitancy and perceptions of disease severity and vaccine safety. PLoS Curr 2015, 7.
18. Payakachat N., Hadden K.B., Ragland D. Promoting Tdap immunization in pregnancy: associations between maternal perceptions and vaccination rates. Vaccine 2015, September.
19. Munoz F.M., Bond N.H., Maccato M., Pinell P., Hammill H.A., Swamy G.K., et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. J Am Med Assoc 2014, 311(May (17)):1760-1769.
20. Kharbanda E.O., Vazquez-Benitez G., Lipkind H.S., Klein N.P., Cheetham T.C., Naleway A., et al. Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes. J Am Med Assoc 2014, 312(November (18)):1897-1904.
21. Donegan K., King B., Bryan P. Safety of pertussis vaccination in pregnant women in UK: observational study. Br Med J 2014, 349:g4219.
22. Shakib J.H., Korgenski K., Sheng X., Varner M.W., Pavia A.T., Byington C.L. Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes. J Pediatr 2013, 163(November (5)). 1422-1426; e1421-1424.
23. Zheteyeva Y.A., Moro P.L., Tepper N.K., Rasmussen S.A., Barash F.E., Revzina N.V., et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol 2012, 207(July (1)). 59; e51-57.
24. Morgan J.L., Baggari S.R., McIntire D.D., Sheffield J.S. Pregnancy outcomes after antepartum tetanus, diphtheria, and acellular pertussis vaccination. Obstet Gynecol 2015, 125(June (6)):1433-1438.
25. Sukumaran L., McCarthy N.L., Kharbanda E.O., Weintraub E.S., Vazquez-Benitez G., McNeil M.M., et al. Safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis and influenza vaccinations in pregnancy. Obstet Gynecol 2015, October.
26. The National Vaccine Advisory Committee: reducing patient and provider barriers to maternal immunizations: approved by the National Vaccine Advisory Committee on June 11, 2014. Public Health Rep 2015, 130(January-February (1)):10-42.
27. Baggs J., Gee J., Lewis E., Fowler G., Benson P., Lieu T., et al. The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics 2011, 127(May (Suppl 1)):S45-S53.
28. Naleway A.L., Gold R., Kurosky S., Riedlinger K., Henninger M.L., Nordin J.D., et al. Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink. Vaccine 2013, 31(June (27)):2898-2903.
29. Naleway A.L., Kurosky S., Henninger M.L., Gold R., Nordin J.D., Kharbanda E.O., et al. Vaccinations given during pregnancy, 2002-2009: a descriptive study. Am J Prev Med 2014, 46(February (2)):150-157.
30. Nordin J.D., Kharbanda E.O., Vazquez-Benitez G., Lipkind H., Lee G.M., Naleway A.L. Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse events. Vaccine 2014, 32(September (39)):4985-4992.
31. Kharbanda E.O., Vazquez-Benitez G., Lipkind H., Naleway A., Lee G., Nordin J.D. Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events. Obstet Gynecol 2013, 122(September (3)):659-667.
32. Kotelchuck M. The Adequacy of Prenatal Care Utilization Index: its US distribution and association with low birthweight. Am J Public Health 1994, 84(September (9)):1486-1489.
33. Kotelchuck M. An evaluation of the Kessner Adequacy of Prenatal Care Index and a proposed Adequacy of Prenatal Care Utilization Index. Am J Public Health 1994, 84(September (9)):1414-1420.
34. Christian L.M., Porter K., Karlsson E., Schultz-Cherry S., Iams J.D. Serum proinflammatory cytokine responses to influenza virus vaccine among women during pregnancy versus non-pregnancy. Am J Reprod Immunol 2013, 70(July (1)):45-53.
35. Goldfarb I.T., Little S., Brown J., Riley L.E. Use of the combined tetanus-diphtheria and pertussis vaccine during pregnancy. Am J Obstet Gynecol 2014, 211(September (3)). 299; e291-295.
36. Tseng H.F., Sy L.S., Qian L., Marcy S.M., Jackson L.A., Glanz J., et al. Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population. Clin Infect Dis 2013, 56(February (3)):315-321.
37. Yih W.K., Nordin J.D., Kulldorff M., Lewis E., Lieu T.A., Shi P., et al. An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink. Vaccine 2009, 27(July (32)):4257-4262.
38. Nordin J.D., Kharbanda E.O., Vazquez-Benitez G., Nichol K., Lipkind H., Naleway A., et al. Maternal safety of trivalent inactivated influenza vaccine in pregnant women. Obstet Gynecol 2013, 121(March (3)):519-525.
39. Thanjan M.T., Ramaswamy P., Lai W.W., Lytrivi I.D. Acute myopericarditis after multiple vaccinations in an adolescent: case report and review of the literature. Pediatrics 2007, 119(June (6)):e1400-e1403.
40. Boccara F., Benhaiem-Sigaux N., Cohen A. Acute myopericarditis after diphtheria, tetanus, and polio vaccination. Chest 2001, 120(August (2)):671-672.
41. Dilber E., Karagoz T., Aytemir K., Ozer S., Alehan D., Oto A., et al. Acute myocarditis associated with tetanus vaccination. Mayo Clin Proc, Mayo Clin 2003, 78(November (11)):1431-1433.
42. Chang S., O'Connor P.M., Slade B.A., Woo E.J. U.S. Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005-2007. Vaccine 2013, 31(February (10)):1447-1452.